Literature DB >> 7027939

Stereotactic treatment of brain lesions. Biopsy, interstitial radiotherapy (iridium-192 and iodine-125) and drainage procedures.

F Mundinger, C B Ostertag, W Birg, K Weigel.   

Abstract

Integrating CT imaging techniques into stereotactic procedures makes it easy to puncture cysts, take biopsies from neoplastic and nonneoplastic lesions, and place radioactive material in tumors at exact and reproducible sites. A stereotactic program of interstitial radiotherapy in deep-seated brain tumors has been applied in 326 cases as of December 31, 1979 (270 cases using iridium-192 and 56 cases using iodine-125). The use of iodine-125 is now favored since it requires less radiation protection due to its soft 28-35 keV radiation; at the same time, however, it possesses a comparable half life of 60 days. In 126 cases, stereotactic biopsy was used exclusively for diagnostic purposes followed by open craniotomy or conventional radiation. Cystic brain tumors (i.e., craniopharyngiomas and cystic low grade gliomas) were permanently drained by insertion of Rickham reservoir catheters in 61 cases. Stereotactic ventriculocisternostomies were carried out in cases of hydrocephalus and drainage of suprasellar arachnoid cysts was performed in 15 cases. A simple method of projecting CT images onto stereotactic X-ray pictures provides an exact mapping of lesions within the actual stereotactic brain space. The results of this series of patients strongly suggest that exploratory craniotomies and free-hand punctures can no longer be advocated. No radiation treatment should be considered without histological confirmation. The more clearly the volume of a tumor can be defined, the more favorable the results of interstitial irradiation in otherwise unresectable tumors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7027939

Source DB:  PubMed          Journal:  Appl Neurophysiol


  9 in total

1.  The utility of external beam radiation and intracystic 32P radiation in the treatment of craniopharyngiomas.

Authors:  Jessica K Schefter; George Allen; Anthony J Cmelak; Mahlon Johnson; Steven Toms; Dennis Duggan; Lewis S Blevins
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

2.  Applications of CT-adapted stereotaxis for the diagnosis and treatment of intracranial lesions.

Authors:  R D Lobato; J J Rivas
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

3.  Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors.

Authors:  Pilar de la Puente; Nicole Fettig; Micah J Luderer; Abbey Jin; Shruti Shah; Barbara Muz; Vaishali Kapoor; Sreekrishna M Goddu; Noha Nabil Salama; Christina Tsien; Dinesh Thotala; Kooresh Shoghi; Buck Rogers; Abdel Kareem Azab
Journal:  J Pharm Sci       Date:  2017-11-21       Impact factor: 3.534

Review 4.  Interstitial brachytherapy and hyperthermia for malignant gliomas.

Authors:  P H Gutin; D C Shrieve; D A Larson; P Sneed
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

5.  Effects of radiotherapy on the astrocytomatous areas of malignant gliomas.

Authors:  D Schiffer; M T Giordana; R Soffietti; R Sciolla; G L Sannazzari; E Vasario
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

6.  In vitro model for the response to irradiation of different types of human intracranial tumours.

Authors:  H Fischer; G H Hartmann; V Sturm; K Schwechheimer; O Krauss; G Schackert; S Kunze
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

7.  Correlation of neuropathologic findings, computerized tomographic and high-resolution ultrasound scans of canine avian sarcoma virus-induced brain tumors.

Authors:  R H Britt; B E Lyons; D R Enzmann; E L Saxer; S H Bigner; D D Bigner
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

8.  Interstitial brachytherapy for low-grade cerebral gliomas: analysis of results in a series of 36 cases.

Authors:  M Scerrati; P Montemaggi; M Iacoangeli; R Roselli; G F Rossi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 9.  Iodine-125 brachytherapy for brain tumours--a review.

Authors:  Silke B Schwarz; Niklas Thon; Katharina Nikolajek; Maximilian Niyazi; Joerg-Christian Tonn; Claus Belka; Friedrich-Wilhelm Kreth
Journal:  Radiat Oncol       Date:  2012-03-06       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.